Provided by Tiger Trade Technology Pte. Ltd.

Novel Coronavirus Treatment

850.364
-2.985-0.35%
Number of Gainers:10
Number of Losers:10
Number of Flat:12
PE:- -
High:859.684
Open:858.226
Low:849.433
Close:853.350
Volume:19.91M
Turnover:274.15M
Market Cap:220.40B
Float Cap:170.09B

Loading ...

BUZZ-Australia's Lark Distilling climbs to 3-1/2-month high as half-yearly loss narrows

Reuters
·
5 hours ago

Skin Elements Ltd-Board Appointments

THOMSON REUTERS
·
9 hours ago

Lark Distilling H1 Gross Profit AUD -1 Million

THOMSON REUTERS
·
12 hours ago

FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms

Reuters
·
16 hours ago

CORRECTED-Australian shares dip on U.S. tariff jitters; miners buck the trend

Reuters
·
Yesterday

BRIEF-Micro-X Refers To Publication On Government Website

Reuters
·
Yesterday

LARK Distilling Names CFO

MT Newswires Live
·
Yesterday

Australian stocks fall as US tariff move sours risk appetite

Reuters
·
Yesterday

NZX Midday Sector Update: Health Technology Soars, Consumer Durables Tank

MT Newswires Live
·
Yesterday

BRIEF-Lark Distilling Co Appoints Paul Bowker As Chief Financial Officer

Reuters
·
Yesterday

Micro-X Ltd - Refers to Publication on Government Website Regarding a$1.5M Technology Development Grant

THOMSON REUTERS
·
Yesterday

Micro-X Ltd - at This Stage, No Fully Executed Contract

THOMSON REUTERS
·
Yesterday

Micro-X Ltd - Confirms It Is in Advanced Stages of Working With Named Partners to Finalise a Development Contract

THOMSON REUTERS
·
Yesterday

Lark Distilling Co Ltd-Appointment of Chief Financial Officer

THOMSON REUTERS
·
Yesterday

Lark Distilling Co Ltd - Appoints Paul Bowker as CFO

THOMSON REUTERS
·
Yesterday

Mesoblast Limited to Host Half-Year Financial Results Webcast

Reuters
·
Feb 20

Australian shares ease after record run; banks anchor weekly advance

Reuters
·
Feb 20

Assessing Ansell’s Valuation After Strong Half Year 2025 Earnings Dividend Hike And Completed Buyback

Simply Wall St.
·
Feb 20

Mesoblast (ASX:MSB) Valuation In Focus As Ryoncil Data And New Trial Plan Signal Clinical Momentum

Simply Wall St.
·
Feb 19

Should Regulatory Scrutiny of Pricing and Legal Challenges Require Action From Woolworths Group (ASX:WOW) Investors?

Simply Wall St.
·
Feb 19